Correlation Between Revolution Medicines and Protagonist Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Protagonist Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Protagonist Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Protagonist Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Protagonist Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Protagonist Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Protagonist Therapeutics.
Diversification Opportunities for Revolution Medicines and Protagonist Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Revolution and Protagonist is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Protagonist Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagonist Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Protagonist Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagonist Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Protagonist Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Protagonist Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.83 times more return on investment than Protagonist Therapeutics. However, Revolution Medicines is 1.2 times less risky than Protagonist Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Protagonist Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 3,355 in Revolution Medicines on March 12, 2024 and sell it today you would earn a total of 679.00 from holding Revolution Medicines or generate 20.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines vs. Protagonist Therapeutics
Performance |
Timeline |
Revolution Medicines |
Protagonist Therapeutics |
Revolution Medicines and Protagonist Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines and Protagonist Therapeutics
The main advantage of trading using opposite Revolution Medicines and Protagonist Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Protagonist Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagonist Therapeutics will offset losses from the drop in Protagonist Therapeutics' long position.Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |